Journals in Medical research

Advances in Biomarker Sciences and Technology

ISSN: 2543-1064

Advances in Biomarker Sciences and Technology (ABST) is a rigorously peer-reviewed, fully open access journal that aims to encompass all aspects of biomarker research, from biomarker development to its applications, clinical diagnosis and treatment to molecular epidemiology and toxicology; from precision medicine to drug development, and from nanotechnology to bioinformatics. ABST focuses on building upon the next generation of biomarkers to accelerate communication of the latest advances in their identification as well as applications. We strive to achieve this objective by providing a high-quality forum for the publication of biomarker-related investigations, including (but not limited to) general research articles elucidating topics in novel technologies, study designs or mathematical models, invited and selected reviews, short communications and editorials.Editorial Board

Advances in Integrative Medicine

ISSN: 2212-9588
5 Year impact factor: 1.3
Impact factor: 1.2

Affiliated with the Australasian Integrative Medicine Association (AIMA)Advances in Integrative Medicine (AIMED) is an international peer-reviewed, evidence-based research and review journal that is multi-disciplinary within the fields of Integrative and Complementary Medicine.The journal focuses on rigorous quantitative and qualitative research including systematic reviews, clinical trials and surveys, whilst also welcoming medical hypotheses and clinically-relevant articles and case studies disclosing practical learning tools for the consulting practitioner.By promoting research and practice excellence in the field, and cross collaboration between relevant practitioner groups and associations, the journal aims to advance the practice of IM, identify areas for future research, and improve patient health outcomes.International networking is encouraged through clinical innovation, the establishment of best practice and by providing opportunities for cooperation between organisations and communities.

Biomedical Journal

ISSN: 2319-4170
5 Year impact factor: 5.4
Impact factor: 4.1

Peer review under responsibility of Chang Gung UniversityBiomedical Journal publishes 6 peer-reviewed issues per year in all fields of clinical and biomedical sciences for an internationally diverse readership for authors from around the world.Clinical studies, accounts of clinical trials, biomarker studies, and characterization of human pathogens are within the scope of the journal, as well as basic studies in model species such as Escherichia coli, Caenorhabditis elegans, Drosophila melanogaster, and Mus musculus revealing the function of molecules, the function of cells, and the characteristics of tissues relevant for human health. However, articles on other species can be published if they contribute to our understanding of basic mechanisms of biology.A highly-cited international editorial board assures timely publication of manuscripts. Reviews on recent progress in biomedical sciences are commissioned by the editors.

Clinical Therapeutics

ISSN: 0149-2918
5 Year impact factor: 3
Impact factor: 3.2

The International Peer-Reviewed Journal of Drug TherapyClinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess drug safety and tolera-bility in all phases of development; new routes of administration and new formulations; pharmacokinetic, bio-availability, and biosimilarity; and changes in practice guidelines and standards, are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.In addition to feature articles published monthly, each issue of Clinical Therapeutics features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not selected for the updates will be considered for general publication. Submit your manuscript at https://www.editorialmanager.com/clinther.

Heliyon

ISSN: 2405-8440
5 Year impact factor: 3.9
Impact factor: 3.4

Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

La Presse Médicale Open

ISSN: 2590-2504

La Presse Médicale Open is a peer-reviewed open access companion journal to La Presse Médicale which focusses on the study, trends and developments of primary care services and community health programs.The journal publishes Original research in the fields of clinical caregeneral medical practiceemergency medicinequalitative researchpublic health problems.

Mechanobiology in Medicine

ISSN: 2949-9070

AimsMechanobiology in Medicine (MBM) aspires to become one of the most prominent publishing venue in mechanobiology by bringing together the most important advances in the discipline, enhancing their visibility by means of opinion and news articles, and providing overviews of the state of the art in each field through topic-, disease- or technology-focused review articles.By publishing content that traverses field boundaries, Mechanobiology in Medicine helps to build bridges between engineers, life scientists, and medical professionals. Mechanobiology is an interdisciplinary discipline that combines biology, engineering, chemistry, physics and medicine. It is a comprehensive and high-tech discipline focused on how physical forces and changes in the mechanical properties of cells and tissues contribute to development, cell differentiation, physiology, and disease-related through understanding mechanotransduction-the molecular mechanisms by which cells sense and respond to mechanical signals.ScopeMechanobiology in Medicine is a peer-reviewed, online, open access journal focused on fundamental research of mechanobiology by studyingthe structure, function and interrelationship within human body at multiple levels using principles and methods of modern natural science and engineering technology, and trying to provide novel insights into how mechanical inputs regulate cell behavior and tissue homeostasis and how their deregulation might cause disease. The journal includes research articles, reviews, and rapid communications with a focus on the mechanobiological advances for disease prevention, diagnosis and treatment.Topics covered in Mechanobiology in Medicine includeCellular and molecular mechanobiology, mechanosensors, mechanotransduction, cellular dynamics, cellular mechanical response, multitissue interactions, and mechanical regulation in diseases and healthMechanobiology in biological processes, mechanical memory, mechanobiology in development, organismal morphogenesis, and tissue and cell remodelingTechnologies in mechanobiology research, biochips, mechanobiology in biomaterials, mechanobiomarkers, single-molecule approaches, and immunoengineeringClinical applications, including translational medicine, regenerative medicine, and drug delivery

Nano TransMed

ISSN: 2790-6760

Nano TransMed is an open access peer-reviewed journal that aims to provide a forum to promote and accelerate the translation of preclinical nano research to a clinical application and the communication between researchers and clinicians in a timely manner.The Journal embraces interdisciplinary and cross-boundary research and linkage between nano technology and clinical applications. Th emphasis is on hot or emerging innovative topics include preclinical applications of novel nanoscale materials, nano delivery system for stem cell-based therapy, nano fabrication and precise tissue engineering, as well as nanotechnology in pharmacology & pharmaceutics, diagnostics, targeted cancer therapy; translational outputs and evidence-based clinical outcomes of nano research. Non-nano works with significant potentials in future nanomedicine may be considered on a case by case basis.The journal contains original research papers, review articles, technical notes, editorials, and letters to the editor about matters that may benefit the wider readership of Nano TransMed.The editors welcome contributions on a variety of topics such as:Translational medicine;Nanomaterials;Nanomedicine;Nanodelivery system;Nano-fabrication;Tissue engineering;Natural product-based nanoparticles;Advanced manufacturing;Smart medical appliances and device;Stem cells;Exosomes and Extracellular Vesicles;Bioanalysis;Nanotechnology in pharmacology & pharmaceutics, diagnostics, targeted cancer therapyEditorial Board

Regenerative Therapy

ISSN: 2352-3204
5 Year impact factor: 3.5
Impact factor: 3.4

Peer review under the responsibility of the Japanese Society for Regenerative Medicine.Regenerative Therapy is the official peer-reviewed online journal of the Japanese Society for Regenerative Medicine.Regenerative Therapy is a multidisciplinary journal that publishes original articles and reviews of basic research, clinical translation, industrial development, and regulatory issues focusing on stem cell biology, tissue engineering, and regenerative medicine.

The American Journal of Pathology

ISSN: 0002-9440
5 Year impact factor: 4.8
Impact factor: 4.7

Discoveries in Basic and Translational Pathobiology Full Text Online Access, and More, to Paid Subscribers at http://ajp.amjpathol.org/The American Journal of Pathology, official journal of the American Society for Investigative Pathology, published by Elsevier, Inc., seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. Foundational studies that incorporate deep learning and artificial intelligence are also welcome. High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches.

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health